PCSK9 and acute kidney injury: Furthermore, inhibiting the PCSK9 protein in endothelial cells can effectively decrease lectin-like oxidation of LDL receptor-1 and reactive oxygen species expression, thereby mitigating inflammation and oxidative stress responses and reducing the risk of CA-AKI.